727 related articles for article (PubMed ID: 19407980)
1. Anti-inflammatory effect of Trichostatin-A on murine bone marrow-derived macrophages.
Han SB; Lee JK
Arch Pharm Res; 2009 Apr; 32(4):613-24. PubMed ID: 19407980
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS.
Halili MA; Andrews MR; Labzin LI; Schroder K; Matthias G; Cao C; Lovelace E; Reid RC; Le GT; Hume DA; Irvine KM; Matthias P; Fairlie DP; Sweet MJ
J Leukoc Biol; 2010 Jun; 87(6):1103-14. PubMed ID: 20200406
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitor KBH-A42 inhibits cytokine production in RAW 264.7 macrophage cells and in vivo endotoxemia model.
Choi Y; Park SK; Kim HM; Kang JS; Yoon YD; Han SB; Han JW; Yang JS; Han G
Exp Mol Med; 2008 Oct; 40(5):574-81. PubMed ID: 18985016
[TBL] [Abstract][Full Text] [Related]
4. Identification of anti-inflammatory target genes of Rhizoma coptidis extract in lipopolysaccharide-stimulated RAW264.7 murine macrophage-like cells.
Kim JM; Jung HA; Choi JS; Lee NG
J Ethnopharmacol; 2010 Jul; 130(2):354-62. PubMed ID: 20546869
[TBL] [Abstract][Full Text] [Related]
5. LPS regulates proinflammatory gene expression in macrophages by altering histone deacetylase expression.
Aung HT; Schroder K; Himes SR; Brion K; van Zuylen W; Trieu A; Suzuki H; Hayashizaki Y; Hume DA; Sweet MJ; Ravasi T
FASEB J; 2006 Jul; 20(9):1315-27. PubMed ID: 16816106
[TBL] [Abstract][Full Text] [Related]
6. Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice.
Choi JH; Nam KH; Kim J; Baek MW; Park JE; Park HY; Kwon HJ; Kwon OS; Kim DY; Oh GT
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2404-9. PubMed ID: 16141407
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide-activated macrophages.
Chen RM; Chen TG; Chen TL; Lin LL; Chang CC; Chang HC; Wu CH
Ann N Y Acad Sci; 2005 May; 1042():262-71. PubMed ID: 15965071
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibition results in decreased macrophage CD9 expression.
Wang XQ; Alfaro ML; Evans GF; Zuckerman SH
Biochem Biophys Res Commun; 2002 Jun; 294(3):660-6. PubMed ID: 12056820
[TBL] [Abstract][Full Text] [Related]
9. Suppression of T cell functions by hydroxamic acid-based histone deacetylase inhibitors.
Kim YH; Lee JK
Arch Pharm Res; 2012 May; 35(5):929-36. PubMed ID: 22644861
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effect of spilanthol from Spilanthes acmella on murine macrophage by down-regulating LPS-induced inflammatory mediators.
Wu LC; Fan NC; Lin MH; Chu IR; Huang SJ; Hu CY; Han SY
J Agric Food Chem; 2008 Apr; 56(7):2341-9. PubMed ID: 18321049
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory effects of annexin-1: stimulation of IL-10 release and inhibition of nitric oxide synthesis.
Ferlazzo V; D'Agostino P; Milano S; Caruso R; Feo S; Cillari E; Parente L
Int Immunopharmacol; 2003 Oct; 3(10-11):1363-9. PubMed ID: 12946433
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of histone deacetylation by trichostatin A intensifies the transcriptions of neuronal c-fos and c-jun genes after kainate stimulation.
Sng JC; Taniura H; Yoneda Y
Neurosci Lett; 2005 Oct; 386(3):150-5. PubMed ID: 16002216
[TBL] [Abstract][Full Text] [Related]
13. E1A has no effect on LPS-induced IL-6 secretion in rat alveolar epithelial cells.
Chen J; Luo J; Li B; Ran P
Respiration; 2009; 78(1):84-92. PubMed ID: 19299891
[TBL] [Abstract][Full Text] [Related]
14. Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro.
Strobl JS; Cassell M; Mitchell SM; Reilly CM; Lindsay DS
J Parasitol; 2007 Jun; 93(3):694-700. PubMed ID: 17626366
[TBL] [Abstract][Full Text] [Related]
15. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.
Vigushin DM; Ali S; Pace PE; Mirsaidi N; Ito K; Adcock I; Coombes RC
Clin Cancer Res; 2001 Apr; 7(4):971-6. PubMed ID: 11309348
[TBL] [Abstract][Full Text] [Related]
16. Induction of soluble antitumoral mediators by synthetic analogues of bacterial lipoprotein in bone marrow-derived macrophages from LPS-responder and -nonresponder mice.
Pfannes SD; Müller B; Körner S; Bessler WG; Hoffmann P
J Leukoc Biol; 2001 Apr; 69(4):590-7. PubMed ID: 11310845
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of iNOS expression and NO production by anti-inflammatory steroids. Reversal by histone deacetylase inhibitors.
Hämäläinen M; Lilja R; Kankaanranta H; Moilanen E
Pulm Pharmacol Ther; 2008; 21(2):331-9. PubMed ID: 17913526
[TBL] [Abstract][Full Text] [Related]
18. Effect of titanium surface topography on macrophage activation and secretion of proinflammatory cytokines and chemokines.
Refai AK; Textor M; Brunette DM; Waterfield JD
J Biomed Mater Res A; 2004 Aug; 70(2):194-205. PubMed ID: 15227664
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
Law AY; Lai KP; Lui WC; Wan HT; Wong CK
Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory activity of Eupatorium perfoliatum L. extracts, eupafolin, and dimeric guaianolide via iNOS inhibitory activity and modulation of inflammation-related cytokines and chemokines.
Maas M; Deters AM; Hensel A
J Ethnopharmacol; 2011 Sep; 137(1):371-81. PubMed ID: 21669270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
